Fast Image-Guided Stratification Using Anti-Programmed Death Ligand 1 Gold Nanoparticles for Cancer Immunotherapy von Meir, Rinat, Shamalov, Katerina, Sadan, Tamar, Motiei, Menachem, Yaari, Gur, Cohen, Cyrille J, Popovtzer, Rachela

Volltext

Targeting TGFβ with chimeric switch receptor and secreted trap to improve T cells anti-tumor activity von Matikhina, Tatyana, Cohen, Cyrille J

Volltext

Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus von Roth, Shalom Hillel, Danan-Gotthold, Miri, Ben-Izhak, Meirav, Rechavi, Gideon, Cohen, Cyrille J., Louzoun, Yoram, Levanon, Erez Y.

Volltext

Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma von Harush, Ortal, Asherie, Nathalie, Kfir-Erenfeld, Shlomit, Adler, Galit, Barliya, Tilda, Assayag, Miri, Gatt, Moshe E, Stepensky, Polina, Cohen, Cyrille J

Volltext

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function von Hoogi, Shiran, Eisenberg, Vasyl, Mayer, Shimrit, Shamul, Astar, Barliya, Tilda, Cohen, Cyrille J.

Volltext

In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications von Betzer, Oshra, Meir, Rinat, Dreifuss, Tamar, Shamalov, Katerina, Motiei, Menachem, Shwartz, Amit, Baranes, Koby, Cohen, Cyrille J., Shraga-Heled, Niva, Ofir, Racheli, Yadid, Gal, Popovtzer, Rachela

Volltext

A novel role for an old target: CD45 for breast cancer immunotherapy von Raiter, Annat, Zlotnik, Oran, Lipovetsky, Julia, Mugami, Shany, Dar, Shira, Lubin, Ido, Sharon, Eran, Cohen, Cyrille J., Yerushalmi, Rinat

Volltext

Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes von Johnson, Laura A, Heemskerk, Bianca, Powell, Daniel J., Jr, Cohen, Cyrille J, Morgan, Richard A, Dudley, Mark E, Robbins, Paul F, Rosenberg, Steven A

Volltext

Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor von Eisenberg, Vasyl, Shamalov, Katerina, Meir, Shimrit, Hoogi, Shiran, Sarkar, Rhitajit, Pinker, Shirel, Markel, Gal, Porgador, Angel, Cohen, Cyrille J

Volltext

Noninvasive Tracking of Natural Killer Cells Using Gold Nanoparticles von Shamalov, Katerina, Meir, Rinat, Motiei, Menachem, Popovtzer, Rachela, Cohen, Cyrille J

Volltext

Genetically engineering glycolysis in T cells increases their antitumor function von Toledano Zur, Raphaëlle, Atar, Orna, Barliya, Tilda, Hoogi, Shiran, Abramovich, Ifat, Gottlieb, Eyal, Ron-Harel, Noga, Cohen, Cyrille J

Volltext

TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection von Alfei, Francesca, Kanev, Kristiyan, Hofmann, Maike, Wu, Ming, Ghoneim, Hazem E., Roelli, Patrick, Utzschneider, Daniel T., von Hoesslin, Madlaina, Cullen, Jolie G., Fan, Yiping, Eisenberg, Vasyl, Wohlleber, Dirk, Steiger, Katja, Merkler, Doron, Delorenzi, Mauro, Knolle, Percy A., Cohen, Cyrille J., Thimme, Robert, Youngblood, Benjamin, Zehn, Dietmar

Volltext

The mutational status of p53 can influence its recognition by human T-cells von Shamalov, Katerina, Levy, Shlomo N., Horovitz-Fried, Miryam, Cohen, Cyrille J.

Volltext

Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T‑Cells in Vivo with Gold Nanoparticles and CT Imaging von Meir, Rinat, Shamalov, Katerina, Betzer, Oshra, Motiei, Menachem, Horovitz-Fried, Miryam, Yehuda, Ronen, Popovtzer, Aron, Popovtzer, Rachela, Cohen, Cyrille J

Volltext

Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides von Besser, Hanan, Yunger, Sharon, Merhavi-Shoham, Efrat, Cohen, Cyrille J, Louzoun, Yoram

Volltext

Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide von Alon, Danny, Paitan, Yossi, Robinson, Eyal, Ganor, Nirit, Lipovetsky, Julia, Yerushalmi, Rinat, Cohen, Cyrille J., Raiter, Annat

Volltext

Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity von Ankri, Chen, Shamalov, Katerina, Horovitz-Fried, Miryam, Mauer, Shmuel, Cohen, Cyrille J

Volltext

Targeting glycosylated antigens on cancer cells using siglec‐7/9‐based CAR T‐cells von Meril, Sara, Harush, Ortal, Reboh, Yishai, Matikhina, Tatyana, Barliya, Tilda, Cohen, Cyrille J.

Volltext

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes von Cohen, Cyrille J, Gartner, Jared J, Horovitz-Fried, Miryam, Shamalov, Katerina, Trebska-McGowan, Kasia, Bliskovsky, Valery V, Parkhurst, Maria R, Ankri, Chen, Prickett, Todd D, Crystal, Jessica S, Li, Yong F, El-Gamil, Mona, Rosenberg, Steven A, Robbins, Paul F

Volltext

T-cells “à la CAR-T(e)” – Genetically engineering T-cell response against cancer von Eisenberg, Vasyl, Hoogi, Shiran, Shamul, Astar, Barliya, Tilda, Cohen, Cyrille J.

Volltext